The North America Medical Cannabis Market Size was valued at USD 15.2 Billion in 2022 to USD 58.6 Billion by 2032 at a CAGR of 14.4% during the forecast period 2022-2032. Medical cannabis, often known as medical marijuana, is a herbal treatment derived from Cannabis plants that are used to treat certain symptoms or conditions such as cancer, chronic pain, and mental problems. THC and CBD are the major cannabinoids derived from this plant that give medical effects. The market is increasing as a result of increased R&D activities and funding help from a variety of corporate and governmental entities.